ascopubs.org: Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk ascopubs.org: Upgrade rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ. Upgrade rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ. The spectrum of breast lesions, including atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA), represents a ...

Understanding the Context

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study Patients participating in surveillance after an LCIS diagnosis are ... MSK created this program because we’re experts in treating this type of cancer. Lobular breast cancer is very different from invasive ductal carcinoma, the most common type of breast cancer. It’s ...

Key Insights

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...